Personalized heart care: biomarker score may cut heart risks
NCT ID NCT04755413
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using a blood test score (based on four proteins linked to heart risk) can help doctors choose the best treatments for people with coronary artery disease. 276 adults with stable heart disease will either get standard care or a customized plan that includes lifestyle advice and medications like statins. The goal is to see if the personalized approach lowers these biomarker levels and reduces complications like heart attacks or hospitalizations.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Lifestyle advice, statins, ezetimibe, and other medications tailored to biomarker levels
- What this could lead to
- If successful, this approach could help doctors personalize heart disease treatment to reduce the risk of heart attacks and other complications.
- What could go wrong
- This is a relatively small, early-stage study focused on biomarker changes, not yet proven to prevent major heart events. The results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Emory Johns Creek Hospiatl
Atlanta, Georgia, 30097, United States
-
Emory Saint Joseph's Hospital
Atlanta, Georgia, 30342, United States
-
Emory University Hospital
Atlanta, Georgia, 30322, United States
-
Emory University Hospital Midtown
Atlanta, Georgia, 30308, United States
-
The Emory Clinic
Atlanta, Georgia, 30324, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- Can we predict which heart aneurysms will grow?
- Can a higher dose of adenosine sharpen heart scans?